Home >> ALL ISSUES >> 2013 Issues >> August 2013

August 2013

From the President’s Desk: Workforce advocacy: everyone’s job, 8/13


August 2013—Many people don’t know what we pathologists do. This is concerning, especially when some of the same people are responsible for determining levels and allocation of funding for graduate medical education, keeping our training programs open, or encouraging careers in pathology. I hope this column ignites a sense of urgency around funding for pathology training and recruiting a strong workforce, for without both our patients will suffer an indefensible loss.

Read More »

Anatomic Pathology Selected Abstracts, 8/13

August 2013—Endometrium as a primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers; Criteria and pitfalls in diagnosis of lymphovascular invasion in prostatectomy specimens; An interobserver study of reproducibility in subtyping pulmonary adenocarcinomas; Value of PAX8, PAX2, claudin-4, and h-caldesmon in identifying peritoneal epithelioid mesotheliomas; Clinicopathologic study of cutaneous digital papillary adenocarcinoma;

Read More »

Cytopathology and More | Managing abnormal screening results: highlights of new guidelines

August 2013—The field of cervical cancer screening saw many developments in 2012. In April last year, the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology published new guidelines for cervical cancer screening, most notably raising the age at which screening should begin, extending the interval between screening tests, and giving preference to simultaneous Pap and human papillomavirus co-testing in women ages 30 to 65. Almost simultaneously, the U.S. Preventive Services Task Force published similar screening guidelines.

Read More »

Importance of screening for Lynch syndrome in patients with EC

August 2013—CAP TODAY and the Association for Molecular Pathology have teamed up to bring molecular case reports to CAP TODAY readers. Here, this month, is the second such case. AMP members write the reports using clinical cases from their own practices thaAMP-CT-Logo3t show molecular testing’s important role in diagnosis, prognosis, treatment, and more. Case report No. 2 comes from Dartmouth-Hitchcock Medical Center, Hanover, NH.

Read More »

Risk, compliance, pay—a juggling act for labs

August 2013—Theatergoers don’t want to see the understudy. Passengers don’t want to encounter a series of “flight delayed” messages on the departures board. And while it may not be every laboratory’s worst nightmare, no pathologist wants to open a letter from a government agency or payer that starts out, “It has come to our attention,” followed with words like “violation” and “false claim.”

Read More »

Microbiology QA, measure for measure

August 2013—In the May 20, 2013 issue of the New Yorker, Google co-founder Sergey Brin is quoted as saying of Internet security: “In big corporations people don’t understand what security people do, for the most part, and no one pays attention to them unless something goes wrong. Frankly, a lot of companies aren’t that interested in security.”

Read More »